Correction to: Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers

Aiqun Li; Karen Yeo; Devin Welty; Haojing Rong

doi:10.1007/s40272-017-0275-8

Correction to: Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers

Paediatr Drugs. 2018 Apr;20(2):205. doi: 10.1007/s40272-017-0275-8.

Authors

Aiqun Li¹, Karen Yeo², Devin Welty¹, Haojing Rong³

Affiliations

¹ Drug Metabolism and Pharmacokinetics, Shire, 300 Shire Way, Lexington, MA, 02421, USA.
² Certara Ltd, Sheffield, UK.
³ Drug Metabolism and Pharmacokinetics, Shire, 300 Shire Way, Lexington, MA, 02421, USA. hrong@shire.com.

Abstract

The article "Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a PhysiologicallyBased Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers", written by Aiqun Li, Karen Yeo, Devin Welty, Haojing Rong, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 02nd November, 2017 without open access.

Publication types

Published Erratum